Enhancement by arachidonic acid of the activity of antibiotics<br /> on experimental by multidrug-resistant Pseudomonas aeruginosa sepsis
Journal Title: Αρχεία Ελληνικής Ιατρικής - Year 2002, Vol 19, Issue 5
Abstract
OBJECTIVE Treatment of experimental multidrug-resistant Pseudomonas aeruginosa sepsis with intravenous co-administration of arachidonic acid (AA), ceftazidime and amikacin. METHOD The study was conducted using 21 rabbits, of which 5 were used for the determination of the dose of AA, 5 became septic and were left untreated as controls, 5 became septic and were treated with ceftazidime and amikacin, 5 became septic and were treated with ceftazidime, amikacin and AA, and one became septic and was treated with ceftazidime, amikacin and the diluent of AA. Sepsis was induced by intravenous (IV) administration of one multidrugresistant P. aeruginosa isolate and treatment was given thirty minutes after bacterial challenge. Ceftazidime was administered by bolus IV at 50 mg/kg, amikacin by bolus IV at 15 mg/kg and AA at 25 mg/kg within 10 minutes. Hemodynamic monitoring was performed and blood was sampled at regular time intervals for quantitative culture and determination of the concentrations of malonodialdehyde (MDA), endotoxins (LPS) and antimicrobials. Three hours after treatment the animals were sacrificed and tissue samples were collected for culture. RESULTS Both the controls and the animals treated with ceftazidime and amikacin showed hemodynamic instability characterized by wide fluctuations of blood pressure and bradycardia. Administration of AA resulted in fall of blood pressure followed by stabilization and adequate pulse rate. Reduction of viable cell counts was detected in the blood 3,0 hours after AA administration, and in the mesenterial lymph nodes and the lung. MDA concentrations were raised after the administration of AA whereas concentrations of LPS were similar in all study groups. No correlation was found between MDA and drug levels. CONCLUSIONS AA administered with ceftazidime and amikacin holds new promise for the treatment of multidrug-resistant P. aeruginosa sepsis. Its therapeutic activity might be attributed to its peroxidation properties.
Authors and Affiliations
S. SKIATHITIS, E. GIAMARELLOS-BOURBOULIS, Th. ADAMIS, M. MOUKTAROUDI, V. KOUSOULAS, L. SAMPRAKOS, A. DIONYSSIOU-ASTERIOU, P. KATAYANNAKOS, H. GIAMARELLOU
Keywords
Related Articles
- EP ID EP102096
- DOI -
- Views 74
- Downloads 0
Blood pressure management in patients with acute stroke
The majority of patients with acute stroke present with elevated blood pressure values. Physicians face the therapeutic dilemma of treating or not treating hypertension in acute stroke, and also the challenge of selectin...
Τhe interwoven intracellular signalling pathway of insulin<br /> and its role in the polycystic ovary syndrome <br />
The mode of action of hormones and the intracellular signalling pathways comprise a continuous object of research, especially in the case of insulin, a hormone with a variety of systematic actions. Studies suggest that t...
Διερεύνηση της αποδοτικότητας δημοσίων και ιδιωτικών μονάδων αιμοκάθαρσης
Σκοπός της παρούσας μελέτης ήταν η εκτίμηση της αποδοτικότητας των δημοσίων και ιδιωτικών μονάδων αιμοκάθαρσης που λειτουργούν στη χώρα μας και η διερεύνηση του πώς επηρεάζεται από το είδος και το πλήθος των εισροών που...
The problem of viral resistance in chronic hepatitis B therapy
Available agents for the treatment of chronic HBV infection include interferon-alpha, the nucleoside analogues lamivudine, telbivudine, entecavir and the noucleotide analogue adefovir and tenofovir. When nucleoside-nucle...
Primary vasculitis of the central nervous<br /> system in a patient with human<br /> immunodeficiency virus infection<br />
Primary vasculitis of the central nervous system (CNS) is a rare manifestation of AIDS. CNS vasculitis is usually related to opportunistic infections or neoplastic disease and the human immunodeficiency virus (HIV) it...